NCT03492840View on ClinicalTrials.gov

Treatment of Women With Lipedema Involving Substantial Fat Knee of Women and Men With Nodular Dercum's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 28, 2018

Primary Completion Date

May 2, 2019

Study Completion Date

May 2, 2019

Conditions
LipedemaDercum Disease
Interventions
DRUG

RZL-012

The dosing regimen will be a single dose treatment injection of RZL-012 in multiple sites

Trial Locations (1)

85724

University of Arizona Medical Center, Tucson

All Listed Sponsors
collaborator

University of Arizona

OTHER

lead

Raziel Therapeutics Ltd.

INDUSTRY

NCT03492840 - Treatment of Women With Lipedema Involving Substantial Fat Knee of Women and Men With Nodular Dercum's Disease | Biotech Hunter | Biotech Hunter